Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02892955 · ClinicalTrials.gov registry record · NA
MOMENTUM 3 Continued Access Protocol
A NA study of Advanced Refractory Left Ventricular Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 1,685
- Enrollment target
- 20
- Study locations
NCT02892955 is a NA study of Advanced Refractory Left Ventricular Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,685 participants. The trial reports 20 study locations across 9 states.
The verdict
NCT02892955, a NA study of Advanced Refractory Left Ventricular Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,685 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the study is to continue to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the the MOMENTUM 3 IDE Study.
Conditions Studied
Interventions
- DEVICE HeartMate 3 LVAS
Study Locations (20)
California
- Cedars Sinai Medical Center - Beverly Hills
- University of California, San Diego - La Jolla
- Sutter Memorial Hospital - Sacramento
- Sharp Memorial Hospital - San Diego
- California Pacific Medical Center - San Francisco
- Stanford University - Stanford
Florida
- Shands Hospital @ University of Florida - Gainesville
- Florida Hospital - Orlando
- Tampa General Hospital - Tampa
Illinois
- Northwestern Memorial Hospital - Chicago
- University of Chicago Medical Center - Chicago
- Advocate Christ Medical Center - Oak Lawn
Georgia
- Piedmont Heart Institute - Atlanta
- Emory University Hospital - Atlanta
Indiana
- IU Health/Methodist Hospital - Indianapolis
- St. Vincent Hospital - Indianapolis
Arkansas
- Baptist Health Medical Center - Little Rock - Little Rock
Colorado
- University of Colorado Hospital - Aurora
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,685 participants |
| Start Date | 2016-08 |
| Est. Completion | 2021-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02892955
The ClinicalTrials.gov registry entry for NCT02892955 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,685 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Advanced Refractory Left Ventricular Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which HeartMate 3 LVAS is the first listed.
NCT02892955 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT02892955 about?
NCT02892955 is a clinical study titled "MOMENTUM 3 Continued Access Protocol". The objective of the study is to continue to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the the MOMENTUM 3 IDE Study.
What is the current status of trial NCT02892955?
This trial is currently completed. It is a NA study. The enrollment target is 1,685 participants. The study started on 2016-08. Estimated completion is 2021-03.
What conditions does trial NCT02892955 study?
This clinical trial studies the following conditions: Advanced Refractory Left Ventricular Heart Failure.
What interventions are being tested in trial NCT02892955?
The interventions under investigation include: HeartMate 3 LVAS (DEVICE).
Who is sponsoring clinical trial NCT02892955?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02892955 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.